The role of pharmacogenomics in Advancing Personalised Medicine: Implications for Drug Efficacy Safety and clinical practice Integration

Saleem Asghar; Muhammad Kashif Shahzad Virk; Bushra Taskeen; Maham Fatima; Hasnain; Abali Wandala

doi:10.70749/ijbr.v3i5.1407

Authors

Saleem Asghar Faculty of Pharmacy, University of Sindh, Jamshoro, Pakistan
Muhammad Kashif Shahzad Virk Department of Specialized Healthcare & Medical Education , Government of the Punjab, Lahore, Pakistan
Bushra Taskeen Hitec institute of medical sciences, Taxila Cantt, Pakistan
Maham Fatima Nishtar Medical University, Multan, Pakistan
Hasnain Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Pakistan
Abali Wandala Universidad Adventista del Plata, Entre-Ríos, Paraná, Argentina

DOI:

https://doi.org/10.70749/ijbr.v3i5.1407

Keywords:

Pharmacogenomics, Drug Efficacy, Personalized Medicine, Adverse Drug Reactions, Genetic Variants, Clinical Integration, Precision Medicine

Abstract

This study explores the role of pharmacogenomics in advancing personalized medicine, with a focus on improving drug efficacy, minimizing adverse drug reactions (ADRs), and integrating genomic data into clinical decision-making. As personalized medicine continues to evolve, pharmacogenomics offers a transformative approach by tailoring drug therapy based on individual genetic profiles. The study employed a quantitative, experimental research design, targeting 159 clinical pharmacologists and medical practitioners from Punjab, Pakistan. Participants were selected through purposive sampling, and data were collected using structured questionnaires assessing knowledge, application, and outcomes related to pharmacogenomic testing. Statistical analyses included chi-square tests to evaluate the impact on ADRs and efficacy, logistic regression to examine the correlation between specific gene variants (CYP2D6, CYP2C9, CYP2C19) and drug response, and ANOVA to assess the effectiveness of integrating pharmacogenomic guidelines into clinical practice. Results revealed a statistically significant improvement in treatment outcomes and reduced ADRs among patients who received genotype-guided therapy. Furthermore, strong associations were identified between genetic variants and medication responses, validating the predictive value of pharmacogenomic data. The study concludes that with proper integration, pharmacogenomics can play a vital role in optimizing patient care and promoting safer, more effective treatment strategies.

Downloads

Download data is not yet available.

References

Vizirianakis, I.S., Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes. Nanomedicine: Nanotechnology, Biology and Medicine, 2011. 7(1): p. 11-17.

https://doi.org/10.1016/j.nano.2010.11.002

TumkurSattar, A.H., et al., Investigate how genetic variations impact drug response and explore the integration of pharmacogenomics into clinical practice. European Journal of Cardiovascular Medicine, 2023. 13(4).

Olorunsogo, T.O., et al., Bioinformatics and personalized medicine in the US: A comprehensive review: Scrutinizing the advancements in genomics and their potential to revolutionize healthcare delivery. World Journal of Advanced Research and Reviews, 2024. 21(1): p. 335-351.

https://doi.org/10.30574/wjarr.2024.21.1.0016

Harper, A.R. and E.J. Topol, Pharmacogenomics in clinical practice and drug development. Nature biotechnology, 2012. 30(11): p. 1117-1124.

https://doi.org/10.1038/nbt.2424

Scott, S.A., Personalizing medicine with clinical pharmacogenetics. Genetics in medicine, 2011. 13(12): p. 987-995.

https://doi.org/10.1097/gim.0b013e318238b38c

Marques, L., et al., Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics, 2024. 16(3): p. 332.

https://doi.org/10.3390/pharmaceutics16030332

Klein, M.E., M.M. Parvez, and J.-G. Shin, Clinical implementation of pharmacogenomics for personalized precision medicine: barriers and solutions. Journal of pharmaceutical sciences, 2017. 106(9): p. 2368-2379.

https://doi.org/10.1016/j.xphs.2017.04.051

Showbharnikhaa, S., M. Vijayalakshmi, and T. Akshaya, Unlocking the Genetic Code: Pharmacogenomics and the Potential of Personalized Medicine. Journal of Pharma Insights and Research, 2024. 2(1): p. 050-055.

Venkatachalapathy, P., et al., Pharmacogenomics and personalized medicine in type 2 diabetes mellitus: potential implications for clinical practice. Pharmacogenomics and Personalized Medicine, 2021: p. 1441-1455.

https://doi.org/10.2147/pgpm.s329787

Sarwar, E., Clinical Significance of Precision Medicine–Genomics and Pharmacogenomics (PGx), in Global Perspectives on Precision Medicine: Ethical, Social and Public Health Implications. 2023, Springer. p. 33-54.

https://doi.org/10.1007/978-3-031-28593-6_3

Babu, B.K., Personalized Medicine and Advancements in Pharmacology: Shaping the Future of Healthcare. International Journal of Pharmaceutical Investigation, 2024. 14(2).

https://doi.org/10.5530/ijpi.14.2.41

Smith, A.W., et al., Systematic symptom management in the IMPACT consortium: rationale and design for 3 effectiveness-implementation trials. JNCI Cancer Spectrum, 2023. 7(6): p. pkad073.

Vippamakula, S., S. Sujatha, and P.S. Mahalakshmi, Correlation of Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics, in A Short Guide to Clinical Pharmacokinetics. 2024, Springer. p. 121-156.

https://doi.org/10.1007/978-981-97-4283-7_7

Shahid, F., Personalized Drug Development: Tailoring Therapies For Individual Genetic Profiles. Journal of Translational Research, 2024. 1(01): p. 31-38.

https://doi.org/10.52783/pst.1210

Pirmohamed, M., Personalized pharmacogenomics: predicting efficacy and adverse drug reactions. Annual review of genomics and human genetics, 2014. 15(1): p. 349-370.

https://doi.org/10.1146/annurev-genom-090413-025419

Mancinelli, L., M. Cronin, and W. Sadée, Pharmacogenomics: the promise of personalized medicine. Aaps Pharmsci, 2000. 2: p. 29-41.

https://doi.org/10.1208/ps020104

Singh, D.B., The impact of pharmacogenomics in personalized medicine. Current applications of pharmaceutical biotechnology, 2020: p. 369-394.

https://doi.org/10.1007/10_2019_110

Cecchin, E. and G. Stocco, Pharmacogenomics and personalized medicine. 2020, MDPI. p. 679.

https://doi.org/10.3390/genes11060679

Mooney, S.D., Progress towards the integration of pharmacogenomics in practice. Human genetics, 2015. 134: p. 459-465.

https://doi.org/10.1007/s00439-014-1484-7

Haga, S.B., The critical role of pharmacists in the clinical delivery of pharmacogenetics in the US. Pharmacy, 2023. 11(5): p. 144.

https://doi.org/10.3390/pharmacy11050144

Vassy, J.L., et al., Impact of SLCO 1B1 pharmacogenetic testing on patient and healthcare outcomes: a systematic review. Clinical Pharmacology & Therapeutics, 2019. 106(2): p. 360-373.

https://doi.org/10.1002/cpt.1223

Singh, A.V., et al., Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology. Biomedicine & Pharmacotherapy, 2023. 163: p. 114784.

https://doi.org/10.1016/j.biopha.2023.114784

Ta, R., M.A. Cayabyab, and R. Coloso, Precision medicine: a call for increased pharmacogenomic education. Personalized Medicine, 2019. 16(3): p. 233-245.

https://doi.org/10.2217/pme-2018-0107

MOUSTAFA, S., Sophisticated application of pharmacogenomics in personalised medicine. 2023, Monash University.

Haga, S.B., Precision medicine: Overview and challenges to clinical implementation. Principles of Gender-Specific Medicine, 2023: p. 513-529.

https://doi.org/10.1016/b978-0-323-88534-8.00020-1

Relling, M.V. and W.E. Evans, Pharmacogenomics in the clinic. Nature, 2015. 526(7573): p. 343-350.

https://doi.org/10.1038/nature15817

Johnson, S.G., Leading clinical pharmacogenomics implementation: advancing pharmacy practice. American Journal of Health-System Pharmacy, 2015. 72(15): p. 1324-1328.

https://doi.org/10.2146/ajhp140613

Paswan, K., et al., The Role of Pharmacogenomics in Optimizing Drug Therapy and Reducing Adverse Reactions. Journal of Pharmacology, Genetics and Molecular Biology (JPGMB), 2025. 1(2): p. 30-49.

Hatem, N.A., Advancing Pharmacy Practice: The Role of Intelligence-Driven Pharmacy Practice and the Emergence of Pharmacointelligence. Integrated Pharmacy Research and Practice, 2024: p. 139-153.

https://doi.org/10.2147/iprp.s466748